Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.84 USD | +2.55% | +3.33% | -17.57% |
09/05 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Oncternal Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.57% | 2.55Cr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
-22.99% | 1.87TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Cantor Fitzgerald Initiates Oncternal Therapeutics With Overweight Rating, $4 Price Target